Aude Peden, Ph.D., helps domestic and international life sciences innovators protect their valuable biotechnology, pharmaceutical, dietary supplement, and cosmetic intellectual property assets. Her past academic research experience gives her insight into the time, effort, challenges, creativity, and interdisciplinary thinking that gives rise to innovative technologies, allowing her to provide practical strategic advice for both defensive and offensive patent protection.

Aude’s practice focuses on patent counseling and procurement, freedom-to-operate analysis, counseling on infringement and invalidity issues, and due diligence as part of licensing and merger and acquisition negotiations. The companies she works with develop technology in a variety of fields, including genetically modified organisms, such as mammals and microorganisms; genetically modified cells, such as stem cells and chimeric antigen receptor (CAR) T cells for use in immunotherapy; recombinant molecules, such as small molecules, antibodies, and genes; vaccines, such as peptides, DNA, or mRNA vaccines; dietary supplements; diagnostic molecules; clean technology (recombinant microorganisms); and cosmetics. She is a member of the Chemical, Biotechnology & Pharmaceutical Practice.

Prior to joining Foley, Aude was an intern in the Office of the General Counsel and Office for Interactions with Industry at Partners HealthCare System (now known as Mass General Brigham). Prior to law school, Aude was an academic research scientist at the University of Utah, Salt Lake City/Howard Hughes Medical Institute, and the University of Texas, Knoxville. She also served as an intern in the Office of the General Counsel and Office for Interactions with Industry at Partners HealthCare System (now known as Mass General Brigham).